IP Library Granted Patent US 8,034,583
Granted Patent B2
US 8,034,583 · App. 12/141,522 · Granted Oct 11, 2011

Metabolically engineered bacterial strains having non-functional endogenous gluconate transporters

Assignee: Danisco US Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,034,583
App. No.
12/141,522
Granted
Oct 11, 2011
Kind
B2
Abstract

The present invention relates to engineering metabolic pathways in bacterial host cells which results in enhanced carbon flow for the production of ascorbic acid (ASA) intermediates. In particular, the invention relates to increasing the production of ASA intermediates in bacterial cells by enhancing the availability of gluconate resulting from the inactivation of endogenous gluconate transporter genes.

Claims (10)

1. An altered Enterobacteriaceae strain comprising an inactivated endogenous gluconate transporter protein, wherein the inactivated endogenous gluconate transporter protein has at least 95% sequence identity with the amino acid sequence of SEQ ID NO: 2, or the amino acid sequence of SEQ ID NO: 4.

2. The altered Enterobacteriaceae strain of claim 1 , comprising a further inactivated endogenous gluconate transporter protein.

3. The altered Enterobacteriaceae strain of claim 1 , wherein the inactivated endogenous gluconate transporter proteins is rendered nonfunctional by deletion of the gene encoding the endogenous gluconate transporter protein.

4. The altered Enterobacteriaceae strain of claim 1 , wherein said Enterobacteriaceae strain is selected from the group of Pantoea, Gluconobacter, Erwinia, Klebsiella , and Escherichia strains.

5. The altered Enterobacteriaceae strain of claim 4 further comprising an inactivated endogenous glucokinase gene.

6. A recombinant Pantoea strain comprising

a) a first inactivated endogenous gluconate transporter gene, wherein the first gluconate transporter gene prior to inactivation encoded a gluconate transporter having at least 90% sequence identity with SEQ ID NO: 2,

b) a second inactivated endogenous gluconate transporter gene, wherein the second gluconate transporter gene prior to inactivation encoded a gluconate transporter having at least 90% sequence identity with SEQ ID NO: 4, and

c) an inactivated endogenous glucokinase gene.

7. The recombinant Pantoea strain of claim 6 , wherein the first inactivated endogenous gluconate transporter gene and the second inactivated endogenous gluconate transporter gene have been deleted.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2011
From: DODGE, TIMOTHY C.; KUMAR, MANOJ; VALLE, FERNANDO; RASHID, H. HARUNUR
To: GENENCOR INTERNATIONAL, INC.
Reel/Frame 027033/0436 →
CHANGE OF NAME Recorded Oct 7, 2011
From: GENENCOR INTERNATIONAL, INC.
To: DANISCO US INC.
Reel/Frame 027035/0051 →
Continuity (4)
Division 10842929 · May 10, 2004
Provisional Application 60473310 · May 22, 2003
Provisional Application 60478056 · Jun 11, 2003
Related Publication 20080299614A1 · Dec 4, 2008